This little-known oncology stock could rise more than 70%, says Citi
Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…
Biotechnology
Pfizer (PFE) 2023 Fourth Quarter Earnings Report
Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit as the company's declining Covid business performed better than expected. The…
Merck and J&J CEOs agree to testify at Senate hearing on drug prices
U.S. Senator Bernie Sanders, independent from Vermont, speaks during a People's Action rally, protesting pharmaceutical companies' lobbying against allowing Medicare…
Humana reports grim forecast for 2024 due to rising medical costs
Signs are displayed at a Humana Inc. office building in Louisville, Kentucky, U.S., Sunday, February 3, 2019. Humana is scheduled…
Johnson & Johnson to resolve baby powder investigation
Containers of Johnson and Johnson baby powder are displayed on a shelf at Walgreens on April 5, 2023 in San…
Johnson & Johnson (JNJ) Q4 2023 Earnings
Johnson & Johnson stock chart seen on a smartphone screen. Rafael Enrique | SOPA Images | Light rocket | fake…
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…
Gilead Shares Fall After Disappointing Lung Cancer Study Results
soup images | Light rocket | fake images Actions of Gilead fell more than 9% on Monday after a key…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…
Citi and others are bullish on biotech, medtech and more
2023 was not a good year for the healthcare sector, but some investors expect it to return this year, highlighting…